Apart from predicting MCI progression to AD dementia, common objectives of existing multimodal prediction models included classifying the stages of AD (SCD versus MCI versus AD dementia), detecting the presence of amyloid, tau, or neurodegeneration, and differentiating AD dementia from other types of dementia. This evidence concerns the gene MAPT and Alzheimer disease.